Eloralintide

Eloralintide

Eloralintide

$ 130

Selective Amylin Receptor Agonist Research Peptide

Eloralintide is a next-generation, long-acting amylin receptor agonist formulated for laboratory research involving appetite regulation, satiety signaling, energy balance, and metabolic pathways. As one of Eli Lilly’s newest investigational metabolic research compounds, eloralintide has become an area of growing scientific interest for its selective amylin receptor activity and potential role as both a standalone research peptide and in combination with incretin-based compounds.

This compound is supplied at >99% purity and is independently third-party lab tested to verify identity and analytical standards.

Category:

Bulk and Kit Pricing Available, Contact Us For Details.

Description

Scientific Background

Selective amylin receptor agonists have become an important focus of metabolic research due to their role in appetite regulation, gastric emptying, satiety signaling, and energy homeostasis. Amylin is a naturally occurring peptide hormone co-secreted with insulin that complements several metabolic pathways currently under investigation.

Notably:

  • Phase 2 clinical research has evaluated eloralintide in adults with obesity and overweight, reporting clinically meaningful reductions in body weight across multiple study arms.
  • Eloralintide is one of Eli Lilly and Company’s newest investigational metabolic research programs and continues to advance through clinical development.
  • Current research has also explored eloralintide in combination with retatrutide. While retatrutide targets the GLP-1, GIP, and glucagon receptors, eloralintide selectively activates the amylin receptor, introducing a fourth distinct metabolic signaling pathway for investigation. This multi-pathway approach has generated significant scientific interest in obesity and metabolic research.
These publications highlight growing scientific interest in selective amylin receptor activity and multi-pathway metabolic signaling within obesity research.
(References available upon request for laboratory review.)

Why Researchers Select Eloralintide

  • Selective amylin receptor targeting
  • Investigated in metabolic and body-weight research models
  • Explored for appetite regulation and satiety signaling mechanisms
  • Long-acting activity profile observed in research settings
  • Frequently evaluated alongside incretin-based compounds in advanced metabolic research
  • Studied with retatrutide to investigate activation of a fourth metabolic signaling pathway through amylin receptor agonism

 

Product Specifications

  • 99% purity – independently lab tested
  • Supplied as high-purity lyophilized powder
  • Requires reconstitution prior to laboratory use
  • Bacteriostatic water required for mixing (sold separately)
  • Swirl gently to dissolve — do not shake
  • Ensure complete dissolution before handling

 

Storage & Stability

  • Store lyophilized vial in freezer conditions until use
  • Maintain 2–8°C and protect from light
  • Refrigerate after reconstitution
  • Utilize within standard laboratory handling timelines

 

Research Use Notice

This product is intended strictly for laboratory research purposes only. Not for human consumption, therapeutic use, or veterinary application.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products